Related Experiment Video
Updated: Jul 20, 2026
12:18
A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
Published on: January 11, 2020
Cognitive impairment and hospital use
P G Weiler1, J E Lubben, I Chi
1School of Social Welfare, UCLA 90024.
American Journal of Public Health
|September 1, 1991
Summary
Cognitive impairment in older adults significantly increases hospitalization risk. Individuals with cognitive impairment were nearly twice as likely to be hospitalized for longer durations, highlighting a critical public health concern.
Area of Science:
- Gerontology
- Public Health
- Neurology
Background:
- Growing aging population faces increased risk of Alzheimer's Disease and other dementias.
- Cognitive impairment is a known risk factor for nursing home placement.
- Limited research exists on cognitive impairment as a predictor of hospitalization.
Purpose of the Study:
- To investigate the association between cognitive impairment and hospital utilization among community-dwelling elderly.
- To determine if cognitive impairment predicts increased hospital admissions and prolonged stays.
Main Methods:
- Utilized data from the California Senior Survey, a randomly selected cohort of community-dwelling elderly.
- Followed 940 participants for one year to track hospital use.
- Assessed cognitive impairment levels within the study population.
Main Results:
- Approximately 17% of participants exhibited mild to severe cognitive impairment.
- Cognitively impaired individuals were nearly twice as likely to be hospitalized compared to unimpaired individuals.
- Cognitive impairment was associated with a higher likelihood of hospital stays lasting six days or more.
Conclusions:
- Cognitive impairment is a significant risk factor for hospital use in the elderly, even when controlling for other factors.
- Further research is needed to understand the causal pathways linking cognitive impairment and hospitalization.
- Identifying causes can inform strategies to reduce healthcare burdens associated with cognitive decline.
Related Concept Videos
01:30Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function. They...
01:30Cognitive Development During Adulthood
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
01:30Negative and Cognitive Symptoms of Schizophrenia
Negative symptoms of schizophrenia indicate a reduction or absence of typical behaviors and emotional responses found in healthy individuals, while positive symptoms reflect an excess or distortion of normal functioning.
Negative Symptoms
Negative symptoms of schizophrenia manifest as deficits in normal emotional and behavioral functioning, profoundly impacting daily life. Individuals with schizophrenia often display a flat affect, characterized by a near-total absence of emotional expression,...
Negative Symptoms
Negative symptoms of schizophrenia manifest as deficits in normal emotional and behavioral functioning, profoundly impacting daily life. Individuals with schizophrenia often display a flat affect, characterized by a near-total absence of emotional expression,...
01:29Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
01:22Dementia l: Introduction
Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
01:29Hepatic Encephalopathy
DefinitionHepatic encephalopathy is a reversible neurologic syndrome that results from advanced liver dysfunction or portosystemic shunting. It leads to disturbances in cognition, behavior, and motor function due to the brain’s exposure to gut-derived toxins that the liver fails to detoxify.EtiologyThis condition develops either in the setting of acute fulminant hepatitis or progressively during chronic liver disease, such as cirrhosis and portal hypertension. Portosystemic shunting—including...